Company profile: Arcion Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology research and development focused on developing treatments for chronic pain.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Arcion Therapeutics
NLS Pharmaceutics
HQ: Switzerland
Website
- Description: Provider of clinical-stage drug development focused on neurobehavioral and neurocognitive disorders and their pharmacognosia, using a patient-centered, target-specific approach via collaborations with industry and academia. Products include Quilience, an extended-release mazindol for excessive daytime sleepiness and cataplexy in narcolepsy, and Nolazol, a controlled-release mazindol for ADHD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NLS Pharmaceutics company profile →
Psyence
HQ: Canada
Website
- Description: Provider of natural psilocybin products to treat psychological trauma and related diagnosable mental health disorders, including anxiety, depression, PTSD, stress, grief, and bereavement, with a focus on palliative care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Psyence company profile →
Medfield Diagnostics
HQ: Sweden
Website
- Description: Provider of microwave-based medical devices and diagnostics, including the Medfield Strokefinder MD100 for assisting clinical evaluation and triage of suspected intracranial injuries in acute situations. Develops systems for screening brain injuries in prehospital and hospital settings and researches future microwave imaging applications beyond brain injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfield Diagnostics company profile →
Intra-Cellular Therapies
HQ: United States
Website
- Description: Provider of drugs for neuropsychiatric, neurologic, and other CNS disorders, including CAPLYTA for schizophrenia and bipolar depression; lumateperone (long-acting injectable) for major depressive disorder and pediatric indications; ITI-1284 ODT-SL for GAD, agitation, and Alzheimer’s psychosis; PDE1 inhibitors (Lenrispodun for Parkinson’s, ITI-1020 for cancer immunotherapy); ITI-333; and the ITI-1500 non-hallucinogenic psychedelics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intra-Cellular Therapies company profile →
Chase Therapeutics
HQ: United States
Website
- Description: Provider of early-stage, product-based specialty pharmaceuticals, including CTC-413 for symptomatic and neuroprotective treatment of Parkinson’s disease and related disorders (Phase 2), CTC-501 for symptomatic treatment of major depressive disorder (Phase 2), and a Parkinson’s disease bioassay for diagnosis and immediate-response outcome measurement in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chase Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Arcion Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Arcion Therapeutics
2.2 - Growth funds investing in similar companies to Arcion Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Arcion Therapeutics
4.2 - Public trading comparable groups for Arcion Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →